by Rachel LaBreck | Jan 5, 2026 | News
Lakeway, TX — January 5, 2025 — Vigilant Biosciences, a leading innovator and developer of solutions that assist in the early detection of oral cancer, is excited to announce its partnership with AMP as a distributor of its products in the United Kingdom. This...
by Rachel LaBreck | Sep 25, 2025 | News
Vigilant Biosciences® is proud to announce its participation in Dentistry Show London 2025, where it will highlight its groundbreaking BeVigilant™ OraFusion™ System — an advanced diagnostic solution designed to enable earlier detection of oral cancer and improve...
by Rachel LaBreck | Sep 24, 2025 | News
Lakeway, TX – Vigilant Biosciences is pleased to announce the successful approval of its BeVigilant™ OraFusion™ System under the In Vitro Diagnostic Regulation (IVDR), marking a significant milestone for international expansion. Additionally, Vigilant received...
by Rachel LaBreck | Sep 22, 2025 | News
Lakeway, TX – Vigilant Biosciences, a leader in the development of innovative solutions for the early detection of oral cancer, is pleased to announce that the U.S. Food and Drug Administration (FDA) has aligned on clinical requirements for a pivotal multi-site trial...
by Rachel LaBreck | Mar 8, 2025 | News
The BeVigilant™ OraFusion™ System was recently recognized by Inside Dentistry as one of the “10 Dental Technologies That Inspire for 2025.” The article spotlights our innovative, saliva-based test that enables early detection of oral cancer biomarkers right from the...
by Rachel LaBreck | Dec 20, 2024 | News
Breaking Cancer News dives into how Vigilant Biosciences® is advancing the early detection of oral cancer with its BeVigilant™ OraFusion™ System. The article features insights from oral surgeon Dr. William Shepard, who shares how this biomarker-driven saliva test is...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES